- India’s eyewear penetration sits at ~35% while 53% of the population needs glasses – a massive untapped market.
- Lenskart’s fully‑integrated supply chain cuts costs and drives a 33% store‑level EBITDA margin, well above the retail norm.
- The firm runs 2,439 domestic stores plus 705 overseas locations, creating a true omnichannel moat.
- Motilal Oswal’s DCF model implies a 55x FY28 pre‑IND‑AS EBITDA multiple, translating to a INR 600 price target.
- Key risks: consumer credit slowdown, aggressive expansion capital needs, and potential entry of global eyewear giants.
You’re overlooking the biggest growth engine in India’s eyewear market.
Motilal Oswal Keeps BUY on Cholamandalam: 20% AUM Growth, INR 2,000 Target
Motilal Oswal rates Canara HSBC Life Insurance: BUY rating, target INR 180
Why Lenskart’s Vertical Integration Gives It a Cost Edge
Lenskart owns the entire value chain – from frame and lens production in a high‑automation plant to last‑mile delivery via its own logistics hub. This backward integration trims the typical 30‑40% markup that independent retailers bear. The result is a cost of goods sold (COGS) advantage of roughly 12‑15% versus peers, which directly fuels the company’s 33% store‑level pre‑IND‑AS EBITDA margin – a figure that would be enviable even in mature retail sectors.
How the Omnichannel Footprint Expands Market Reach
With 2,439 stores across 435 Indian cities and 705 international outlets, Lenskart blends a digital‑first app experience with brick‑and‑mortar convenience. The app drives over 60% of total sales, while stores act as test‑and‑fit centers, reducing return rates to under 5%. This synergy creates a virtuous cycle: online traffic fuels foot traffic, and in‑store trials boost conversion on the app. Competitors such as Titan Eyeplus and local chains still rely heavily on fragmented supply, limiting their ability to replicate Lenskart’s 10‑month payback period on new stores.
Sector Trends: Organized Retail vs. Unorganized Players
The Indian eyewear category is still 65% unorganized, characterized by small optical shops with limited inventory and no digital presence. As disposable incomes rise and vision health awareness spreads, consumers gravitate toward trusted brands that offer transparent pricing and quick delivery. Lenskart’s house‑of‑brands strategy – from mass‑market frames to premium designer lines – captures the full spectrum of buyer intent, positioning it as the inevitable leader as the sector consolidates.
Competitive Landscape: What Tata & Adani Are Watching
Tata Digital has hinted at a “vision‑care” platform, and Adani’s retail arm is exploring eyewear as a cross‑sell for its fashion stores. However, both lack Lenskart’s manufacturing backbone and data‑driven inventory algorithms. Their entry would likely be in a partnership or acquisition mode rather than a green‑field rollout, giving Lenskart a first‑mover advantage that could be monetized through licensing its tech stack to new entrants.
Historical Parallel: How Warby Parker Scaled in the U.S.
When Warby Parker launched in 2010, the U.S. eyewear market was similarly under‑penetrated, with a 30% adoption rate. By owning its supply chain and leveraging a direct‑to‑consumer model, Warby captured a 15% market share within five years and achieved a 25% EBITDA margin. Lenskart mirrors that trajectory but on a larger, more price‑sensitive population, suggesting even greater upside if execution holds.
Valuation Mechanics: The 55x FY28 EBITDA Multiple
Motilal Oswal’s DCF model projects FY28 pre‑IND‑AS EBITDA of INR 10.9 billion. Applying a 55x multiple yields a fair value of INR 600 per share, roughly a 30% upside from today’s price. While the multiple sits above the typical retail range (15‑25x), it is justified by Lenskart’s superior growth (CAGR > 30% through 2028), high margin profile, and defensible moat. The model assumes a 10% discount rate, reflecting the company’s strong cash‑flow generation and modest leverage.
Key Risks to Watch
1. Capital Intensity: Aggressive store roll‑out requires ~INR 1,200 crore of capex annually. A credit crunch could stretch financing costs.
2. Consumer Credit Quality: The brand’s “buy now, pay later” schemes hinge on low default rates; any uptick could erode margins.
3. Regulatory Shifts: New import duties on raw optical materials could impact cost structures if not offset by in‑house sourcing.
Investor Playbook
Bull Case: Continued under‑penetration, successful international expansion, and rollout of AI‑driven eye‑test kiosks drive revenue > INR 30 billion by FY28. Margins improve to 38% EBITDA, pushing valuation above INR 700 – a 40% upside.
Bear Case: Slower store economics, higher financing costs, and entry of global players compress margins to 25% and force the multiple down to 35x, capping upside at INR 450 – a 20% downside.
Given the macro tailwinds and Lenskart’s entrenched moat, the BUY rating with a INR 600 target remains a compelling risk‑adjusted play for investors seeking exposure to India’s fast‑growing consumer health segment.